Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Promising preliminary phase III results reported for Lyme disease vaccine

Sep. 16, 1997

MGH and BioTransplant report advances in xenotransplantation research

Sep. 16, 1997

In vitro and in vivo antibacterial activity of two herbal medicines

Sep. 12, 1997

BioFocus and RDW begin collaboration for T-cell enzyme inhibitors

Sep. 10, 1997

New orally active immunosuppressant for combination with ciclosporin

Sep. 9, 1997

Roche seeks European approval for humanized monoclonal antibody

Sep. 5, 1997

Russian scientists report on myelopeptides

Sep. 5, 1997

UDCA suppresses allograft rejection after heart transplant

Sep. 3, 1997

Cortecs granted patent for Flustat

Aug. 29, 1997

Cel-Sci reaches supply agreement with American Red Cross

Aug. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...